Table 1.

Association between effector-type Tregs and clinicopathological features in advanced EOC

Factors	High effector-type Tregs/ Cases (%)	P value
Age
< 65	10/19 (52.6)	0.43
65 ≤	11/22 (50.0)
Histology
High-grade serous	16/25 (64.0)	0.042a
Clear cell	2/7 (28.6)
Others	3/9 (50.0)
Stage
IIIC	15/31 (48.4)	0.71
IV	6/10 (60.0)
Tumor size
< 100 mm	14/22 (63.6)	0.13
100 mm ≤	7/19 (36.8)
Residual tumor
Yes	20/38 (52.6)	0.85
No	1/3 (33.3)

^a High-grade serous vs. Clear cell and Others